Yuan Xu

Insider Reports History

Entity
Individual
Location
C/O Akero Therapeutics, Inc., 601 Gateway Boulevard, Suite 350, South San Francisco, CA
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yuan Xu:

Insider Reports Filed by Yuan Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FATE FATE THERAPEUTICS INC Aug 6, 2024 1 -$2.68K 4 Aug 7, 2024 Director
XLO Xilio Therapeutics, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director
AKRO Akero Therapeutics, Inc. Jun 8, 2024 1 $0 4 Jun 11, 2024 Director
FATE FATE THERAPEUTICS INC Jun 7, 2024 1 $0 4 Jun 11, 2024 Director
FATE FATE THERAPEUTICS INC Aug 4, 2023 1 -$2.34K 4 Aug 7, 2023 Director
AKRO Akero Therapeutics, Inc. Jun 23, 2023 1 $0 4 Jun 27, 2023 Director
FATE FATE THERAPEUTICS INC Jun 14, 2023 1 -$19.3K 4 Jun 15, 2023 Director
XLO Xilio Therapeutics, Inc. Jun 12, 2023 1 $0 4 Jun 13, 2023 Director
FATE FATE THERAPEUTICS INC Jun 6, 2023 1 $0 4 Jun 7, 2023 Director
XLO Xilio Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
FATE FATE THERAPEUTICS INC Jun 9, 2022 2 $0 4 Jun 13, 2022 Director
AKRO Akero Therapeutics, Inc. Jun 2, 2022 1 $0 4 Jun 3, 2022 Director
XLO Xilio Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Director
XLO Xilio Therapeutics, Inc. Jan 4, 2022 0 $0 3 Jan 6, 2022 Director
FATE FATE THERAPEUTICS INC Aug 3, 2021 2 $0 4 Aug 5, 2021 Director
FATE FATE THERAPEUTICS INC Aug 3, 2021 0 $0 3 Aug 5, 2021 Director
AKRO Akero Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director